Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas

Ajay Major, MDMBA, Justin Kline, MD, Theodore G. Karrison, PhD, Paul A S Fishkin, MD, Amy S Kimball, MD PhD, Adam M Petrich, MD, Sreenivasa Nattam, MD, Bethany G Sleckman, MD, Kenneth Cohen, MD, Koen van Besien, MD PhD, Aaron P. Rapoport, MD, Sonali M. Smith, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-134750

Published: 2020

Journal Articles

A Pilot Study of a Functional Pain Assessment for Adult Patients Admitted with Sickle Cell Pain Crisis

Marquita Nelson, MD, Monica Peek, MDMPH, Kenneth Cohen, MD, Danielle Bowsman, MHA, Nabil Abou-Baker, MD

Blood (2019) 134 (Supplement_1): 4693.

https://doi.org/10.1182/blood-2019-124847

Published: 2019

Journal Articles

Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results

Chadi Nabhan, MD MBA, FACP, Theodore Karrison, PhD, Justin Kline, Kenneth Cohen, MD, Michael R. Bishop, MD, Reem Karmali, MD MS, Aaron P. Rapoport, MD, Parameswaran Venugopal, MD, James Wade, MD, Paul Fishkin, MD, Sonali M. Smith, MD

Blood (2016) 128 (22): 4191.

https://doi.org/10.1182/blood.V128.22.4191.4191

Published: 2016

Journal Articles

Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function

Blood (2005) 105 (5): 2235–2238.

https://doi.org/10.1182/blood-2003-12-4399

Published: 2005

Journal Articles

Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels

Zhengyu Wang, Kenneth Cohen, Ying Shao, Pamela Mole, David Dombkowski, David T. Scadden

Blood (2004) 103 (1): 100–109.

https://doi.org/10.1182/blood-2003-04-1063

Published: 2004

NARROW

Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas

A Pilot Study of a Functional Pain Assessment for Adult Patients Admitted with Sickle Cell Pain Crisis

Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results

Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function

Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels

Email alerts

ASH Publications

American Society of Hematology

Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas

A Pilot Study of a Functional Pain Assessment for Adult Patients Admitted with Sickle Cell Pain Crisis

Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results

Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function

Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only